Hjem › Melanom › Pennsylvania › Philadelphia
Kliniske studier for Melanom i Philadelphia, PA
23 studier for Melanom søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi unna
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
- Fox Chase Cancer Center, Philadelphia
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
- Thomas Jefferson University Hospital, Philadelphia
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RekruttererFase 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi unna
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RekruttererFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi unna
- og 3 flere
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
RekruttererFase 1/2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- og 1 flere
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Tebentafusp-tebn With LDT in Metastatic UM
RekruttererFase 1/2
- Thomas Jefferson University, Philadelphia
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
RekruttererFase 1/2
- Fox Chase Cancer Center, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
RekruttererFase 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
RekruttererTidlig fase 1
- Fox Chase Cancer Center, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruttererFase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RekruttererFase 3
- Jefferson Health Honickman Center, Philadelphia
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
RekruttererFase 2/3
- UPenn, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- Thomas Jefferson University, Philadelphia
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
RekruttererFase 3
- Thomas Jefferson University Medical Oncology Clinic, Philadelphia
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
RekruttererFase 3
- Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Rekrutterer
- University of Pennsylvania, Philadelphia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Fox Chase Cancer Center, Philadelphia
Melanom-studier i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- San Francisco, CA22 studier
- Columbus, OH21 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- Salt Lake City, UT21 studier
- St. Louis, MO21 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.